TrialBritish journal of cancer2018

Phase II trial of palbociclib in patients with metastatic urothelial cancer after failure of first-line chemotherapy.

Tracy L Rose et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.